Clearview Wealth Advisors LLC Novo Nordisk A S Transaction History

Clearview Wealth Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 07, 2023	SELL	$155.98 - $172.65 $3,119 - $3,453	-20 Reduced 4.36%	439 $71,000
Q1 2023 Apr 12, 2023	BUY	$132.34 - $159.14 $2,646 - $3,182	20 Added 4.56%	459 $73,000
Q3 2022 Oct 18, 2022	SELL	$95.28 - $116.93 $2,858 - $3,507	-30 Reduced 6.4%	439 $44,000
Q2 2022 Aug 05, 2022	SELL	$103.24 - $121.81 $3,097 - $3,654	-30 Reduced 6.01%	469 $52,000
Q1 2022 Apr 29, 2022	SELL	$93.1 - $112.54 $23,740 - $28,697	-255 Reduced 33.82%	499 $55,000
Q4 2021 Feb 02, 2022	BUY	$95.88 - $117.08 $20,997 - $25,640	219 Added 40.93%	754 $84,000
Q3 2021 Nov 02, 2021	SELL	$84.42 - $106.62 $68,042 - $85,935	-806 Reduced 60.1%	535 $51,000
Q2 2021 Jul 30, 2021	BUY	$67.66 - $84.76 $90,732 - $113,663	1,341 New	1,341 $112,000

1,957

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $197B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Clearview Wealth Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Clearview Wealth Advisors LLC with notifications on news.